Previous close | 2.6500 |
Open | 2.5500 |
Bid | 2.6000 |
Ask | 2.8000 |
Strike | 12.50 |
Expiry date | 2025-01-17 |
Day's range | 2.5500 - 2.5500 |
Contract range | N/A |
Volume | |
Open interest | 39 |
Over the last year, a good number of insiders have significantly increased their holdings in Liquidia Corporation...
Liquidia stock retook its 50-day line on a U.S. judge's ruling on a patent dispute with United Therapeutics.
On May 31, Judge Andrews denied United Therapeutics’ motion for a preliminary injunction to block the launch of YUTREPIA in the PH-ILD indicationRuling reinforces the clear path for FDA to issue final decision on amended NDA for YUTREPIA to treat both PAH and PH-ILD MORRISVILLE, N.C., June 03, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that on May 31, Judge Andrews of the U.S. District Court for the District of Delaware (District Court) denied the motion for pre